BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25453240)

  • 1. Nausea: current knowledge of mechanisms, measurement and clinical impact.
    Kenward H; Pelligand L; Savary-Bataille K; Elliott J
    Vet J; 2015 Jan; 203(1):36-43. PubMed ID: 25453240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
    Hay Kraus BL
    J Am Vet Med Assoc; 2014 Nov; 245(9):1015-20. PubMed ID: 25313812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of Nausea and Vomiting: Current Knowledge and Recent Advances in Intracellular Emetic Signaling Systems.
    Zhong W; Shahbaz O; Teskey G; Beever A; Kachour N; Venketaraman V; Darmani NA
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nausea and the quest for the perfect anti-emetic.
    Andrews PL; Sanger GJ
    Eur J Pharmacol; 2014 Jan; 722():108-21. PubMed ID: 24157981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-emetic therapy in cancer chemotherapy: current status.
    Herrstedt J; Dombernowsky P
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dolasetron: a new option for nausea and vomiting.
    Ogilvie GK
    J Am Anim Hosp Assoc; 2000; 36(6):481-3. PubMed ID: 11105883
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of nausea and vomiting: gaps in our knowledge.
    Sanger GJ; Andrews PL
    Auton Neurosci; 2006 Oct; 129(1-2):3-16. PubMed ID: 16934536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal plants as antiemetics in the treatment of cancer: a review.
    Haniadka R; Popouri S; Palatty PL; Arora R; Baliga MS
    Integr Cancer Ther; 2012 Mar; 11(1):18-28. PubMed ID: 21821652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of nausea and vomiting in palliative care.
    Neoh K; Adkinson L; Montgomery V; Hurlow A
    Br J Hosp Med (Lond); 2014 Jul; 75(7):391-2, 394-6. PubMed ID: 25040518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The control of chemotherapy-induced nausea and vomiting].
    Shinkai T; Saijo N; Sawamura N; Funaki U; Takahashi S; Yokoyama S; Fujita J; Futami H; Sasaki Y; Shimizu E
    Gan No Rinsho; 1985 Jun; 31(7):779-91. PubMed ID: 3897622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nausea and vomiting in advanced cancer.
    Harris DG
    Br Med Bull; 2010; 96():175-85. PubMed ID: 20884654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-emetic effect of granisetron in patients undergoing cranial and craniospinal radiotherapy].
    Yamasaki F; Watanabe Y; Nosaka R; Kenjo M; Nakamura K; Takayasu T; Saito T; Tominaga A; Sugiyama K; Kurisu K
    No Shinkei Geka; 2014 Jan; 42(1):27-34. PubMed ID: 24388937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
    Stapleton J; Wo JM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism and treatment of nausea and vomiting.
    Nagendran T; Nagendran S
    Ala Med; 1990 Nov; 60(5):12-6. PubMed ID: 2291448
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence and aetiology of postoperative nausea and vomiting.
    Camu F; Lauwers MH; Verbessem D
    Eur J Anaesthesiol Suppl; 1992 Nov; 6():25-31. PubMed ID: 1425622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of navoban in the therapy of oncology patients with highly emetic treatments].
    Russel AJ
    Vopr Onkol; 1995; 41(1):87-90. PubMed ID: 7667952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
    Kodama F; Mohri H; Motomura S; Fukawa H; Tanabe J; Koharasawa H; Kanamori H; Hashimoto Y; Harano H; Sakai R; Tomita N; Fujimaki K; Takemura S; Hattori M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):273-9. PubMed ID: 11865634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral ondansetron for the treatment of chemotherapy- and radiation-induced nausea and vomiting.
    Burnette PK; Perkins J
    Pharmacotherapy; 1992; 12(2):120-31. PubMed ID: 1533280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-emetic efficacy of maropitant (Cerenia) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe.
    de la Puente-Redondo VA; Siedek EM; Benchaoui HA; Tilt N; Rowan TG; Clemence RG
    J Small Anim Pract; 2007 Feb; 48(2):93-8. PubMed ID: 17286662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.